Back to results
CompletedPhase 3

Effect of Sulodexide in Early Diabetic Nephropathy

NCT00130208

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian Clinics, Rush University Medical Center

Chicago, Illinois, United States

+2 additional locations

View on ClinicalTrials.gov
Effect of Sulodexide in Early Diabetic Nephropathy — TrialFind